You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
永安藥業(002365.SZ)上半年淨利潤減少68.77%至3311.44萬元
格隆匯 08-24 02:06

格隆匯8月24日丨永安藥業(002365.SZ)發佈2019年半年度報告,報告期內,公司實現營業收入6.45億元,同比增長27.19%;歸屬於上市公司股東的淨利潤3311.44萬元,同比減少68.77%;歸屬於上市公司股東的扣除非經常性損益的淨利潤2258.6萬元,同比減少77.28%;基本每股收益0.11元。

2019年上半年,國際形勢複雜,全球經濟增長放緩等因素給市場預期帶來較大的不確定性,影響了客户心態和牛磺酸新增產能的釋放,進一步增強了市場競爭。公司管理層緊跟市場形勢,積極調整生產經營策略,雖然收入實現增長,而由於牛磺酸價格持續下行,利潤出現了大幅下滑。

牛磺酸市場經過一輪漲勢後,產品價格逐漸迴歸,毛利率隨之下滑,加之各種不利因素疊加。面對較多的困難,公司迎難而上,努力拓展國內市場,穩定總體市場份額,牛磺酸銷量沒有出現大幅下滑。年產3萬噸牛磺酸食品添加劑生產線逐步穩定運行,各項工藝指標符合預期。新開發的牛磺酸生產工藝在中國、美國和日本取得專利授權,並進一步加大研發投入,不斷更新工藝,保持工藝先進性。公司積極協助律師配合美國ITC的337調查,2019年4月美國ITC終止此次調查,公司知識產權負面影響消除,市場信心恢復。

此外,公司加快推進子公司凌安科技“11.2萬噸/年低碳環氧衍生精細化工新材料”項目建設,二季度進入試生產並穩定運營,其聚醚單體、減水劑母液、及工作液生產銷售大幅增加,銷售收入達到2.07億元,實現利潤1788.06萬元,收入利潤均迅速增長。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account